📰 Johnson Middle News
Page 2 - Johnson Middle News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Johnson Middle. Real-time updates on events, politics, business and more.
August 17, 2022
Aug. 22 is when speed enforcement cameras go live in the city of Fairfax, Virginia, as students return to class.
August 11, 2022
Students at Johnson Middle School over the summer were escorted by adults to the bathroom, and no such assault occurred, a district spokesman said.
June 16, 2022
Police say this serves as a good reminder to put away trash barrels or other food sources at night that may attract bears.
June 16, 2022
Articles from the tag: WALPOLE
June 16, 2022
Town officials are issuing a warning after a black bear was caught on a home surveillance camera Wednesday night in Walpole, Massachusetts.
February 4, 2022
TIMMONSVILLE, S.C. (AP) — Two school board members of a district taken over by South...
August 8, 2021
D.C. Public Schools (DCPS) officials are urging parents to add COVID-19 vaccinations to the list of things students need to start school in the fall. They’ve...
June 11, 2021
Brevard's Official At Work Station!
May 28, 2021
Janssen’s Erleada maintains quality of life for prostate cancer patients 27th May 2021 Janssen’s Erleada in addition to androgen deprivation therapy (ADT) maintained prostate cancer patients’ health-related quality of life (HRQoL), according to new patient-reported outcomes (PRO) data. The PRO data from the prespecified final analysis of the Phase III TITAN study in patients with metastatic hormone-sensitive prostate cancer (mHSPC) also showed that the addition of Erleada (apalutamide) to...
February 9, 2021
Janssen’s Erleada improves survival in certain advanced prostate cancer patients Final analysis demonstrates a 35% reduction in the risk of death in mHSPC patients The final analysis of Janssen’s phase 3 TITAN study has demonstrated continued overall survival (OS) benefit of Erleada plus androgen deprivation therapy (ADT) in certain prostate cancer patients. The TITAN study evaluated Erleada (apalutamide) plus ADT in patients with metastatic hormone-sensitive prostate cancer (mHSPC) compar...